Saturday, October 3, 2026

EUR/CHF Bearish Momentum: 0.87% Down In The Last 5 Sessions

ViaNews Editorial Team

February 6, 2023

EUR/CHF Bearish Momentum: 0.87% Down In The Last 5 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 0.87% for the last 5 sessions. At 05:06 EST on Monday, 6 February, EUR/CHF (EURCHF) is $1.00.

EUR/CHF's yearly highs and lows, it's 5.557% up from its 52-week low and 6.201% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.45%, a positive 0.02%, and a positive 0.29%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.45% (last week), 0.34% (last month), and 0.29% (last quarter), respectively.

News about

  • According to FXStreet on Sunday, 5 February, "Following the news, the USD/JPY pair defends Friday's recovery moves around 131.85, up nearly half a percent intraday."
  • Usd/jpy price analysis: renews three-week high but 50-dma probes bulls. According to FXStreet on Monday, 6 February, "If at all the USD/JPY bears manage to conquer the 128.20 support bottom surrounding 127.20 and May 2022 low near 126.35 could probe them before highlighting the 120.00 round figure.", "Following that, an ascending trend line from mid-January will challenge the USD/JPY sellers around 128.20."
  • Usd/jpy eases from multi-week top, bullish potential intact amid post-nfp USD strength. According to FXStreet on Monday, 6 February, "Apart from this, the broader risk sentiment will drive demand for the safe-haven JPY and contribute to producing short-term opportunities around the USD/JPY pair.", "The prevalent risk-off environment - as depicted by a generally weaker tone around the equity markets - underpins the safe-haven Japanese Yen (JPY) and acts as a headwind for the USD/JPY pair. "
  • Usd/jpy: the ingredients are in place for a renewed move lower – HSBC. According to FXStreet on Monday, 6 February, "A move lower in USD/JPY over the coming few weeks will mostly rely on the outlook for BoJ policy change, but other more medium-term forces (such as improving current account balance) should also be helping in the background."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com